West Pharmaceutical Services Inc. closed 43.99% below its 52-week high of $396.75, which the company achieved on April 8th.

NEW YORK, NY / ACCESS Newswire / March 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West ...

Evercore ISI analyst Daniel Markowitz notes that West Pharmaceutical (WST) shares are down 30% since the company reported Q4 results, but ...

With Q4 behind us, let’s have a look at West Pharmaceutical Services (NYSE:WST) and its peers. Companies specializing in drug development inputs and services play a crucial role in the ...

In the past month, West Pharmaceutical Services observed a 13% rise in its share price. Several key developments could help explain this movement. Firstly, the announcement to amend the company's ...

In the past month, West Pharmaceutical Services observed a 13% rise in its share price. Several key developments could help explain this movement. Firstly, the announcement to amend the company's ...

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

A 300-strong South West-based pharmaceutical firm has posted results featuring a surge in turnover and profits. Qualasept, which is based in Wiltshire, supplies pharmaceutical products and services.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...